REVVITY, INC. is 7.5x more valuable than Alamar Biosciences, Inc. by market capitalization ($11.13 B vs $1.49 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ALMR | RVTY |
|---|---|---|
| Market cap | $1.49 B | $11.13 B |
| US-listed rank | #2318 | #887 |
| Revenue (latest FY) | - | $2.86B |
| Net income (latest FY) | - | $241.20M |
| Net margin | - | 8.4% |
| P/E (trailing FY) | - | 46.1 |
| SEC filings | 38 | 1,736 |
REVVITY, INC. is 7.5x more valuable than Alamar Biosciences, Inc. by market capitalization ($11.13 B vs $1.49 B).
Full pages: Alamar Biosciences, Inc. and REVVITY, INC., or browse the full rankings.